(MedPage Today) -- He spoke fast, hammering through the Trump administration's efforts to lower prescription drug prices, combat healthcare fraud, and curb the spread of Ebola overseas. But when reporters tried to ask Mehmet Oz, MD, MBA, about...
(MedPage Today) -- Two scientists at a U.S. government lab were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it during interviews with investigators at a Michigan airport, authorities said...
(MedPage Today) -- All grants approved by the NIH for funding are now going through extra screening at HHS. HHS staffers -- who may be political appointees and not subject matter experts -- have sometimes asked to make substantive changes to...
(MedPage Today) -- CHICAGO -- A randomized trial testing the addition of selinexor (Xpovio) to ruxolitinib (Jakafi) for myelofibrosis only met one of its two primary endpoints, yet the combination also showed a potential survival benefit. At...
(MedPage Today) -- Note that some links may require registration or subscription. Rep. Thomas Kean Jr. (R-N.J.) has been absent from Congress for several months due to what he says is a "personal medical issue," and New York Times reporters have...
(MedPage Today) -- LONDON -- An investigational monoclonal antibody drug for immunoglobulin (Ig)G4-related disease called obexelimab substantially outperformed placebo in the phase III INDIGO trial, researchers reported, positioning it to take...
(MedPage Today) -- People with knee osteoarthritis (OA) who used GLP-1 receptor agonists were less likely to undergo knee replacement surgery, an analysis of a large records database indicated. Compared with otherwise similar OA patients not taking...
(MedPage Today) -- CMS issued an interim final rule Monday outlining implementation rules for new Medicaid work requirements, and health organizations seemed none too happy with it. "Most adults covered by Medicaid are already working, caregiving...
(MedPage Today) -- CHICAGO -- Combining standard transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE regimen improved progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), the phase...
(MedPage Today) -- Buffalo Wild Wings now offers an unusual new drink: "Espresso Proteini." Marketed for National Espresso Martini Day, the $12 drink includes 10 grams of Muscle Milk protein powder with a signature Buffalo dry rub rim. While the...
(MedPage Today) -- CHICAGO -- Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients in low-resource countries with recurrent or metastatic head and neck squamous...